• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up.

作者信息

Trimble E L

机构信息

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20894.

出版信息

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S1-3. doi: 10.1006/gyno.1994.1332.

DOI:10.1006/gyno.1994.1332
PMID:7835792
Abstract
摘要

相似文献

1
The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up.美国国立卫生研究院卵巢癌共识会议：筛查、治疗与随访
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S1-3. doi: 10.1006/gyno.1994.1332.
2
NIH develops consensus statement on ovarian cancer.美国国立卫生研究院制定关于卵巢癌的共识声明。
Am Fam Physician. 1994 Jul;50(1):213-6.
3
[Ovarian cancer. Screening, therapy and follow-up].[卵巢癌。筛查、治疗与随访]
Gynakol Geburtshilfliche Rundsch. 1994;34(2):123-9. doi: 10.1159/000272350.
4
Panel rejects calls for routine screening for ovarian cancer, cites role for paclitaxel.专家小组驳回了对卵巢癌进行常规筛查的呼吁，提及了紫杉醇的作用。
Am J Hosp Pharm. 1994 Jun 1;51(11):1381-2.
5
Patient page #63. Ovarian cancer. What you need to know!患者手册第63页。卵巢癌。你需要了解的内容！
J Okla State Med Assoc. 2005 Sep;98(9):466-7.
6
Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.卵巢癌风险的担忧以及卵巢癌高危女性对卵巢癌筛查的使用情况。
Gynecol Oncol. 2002 Apr;85(1):3-8. doi: 10.1006/gyno.2001.6556.
7
The National Cancer Institute Multi-Screening Trial.美国国立癌症研究所多筛试验
Can J Oncol. 1994 Nov;4 Suppl 1:98-9; discussion 100-1.
8
Clinical and laboratory directions for ovarian cancer research.卵巢癌研究的临床与实验室指南。
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S164-7. doi: 10.1006/gyno.1994.1357.
9
Ovarian cancer.卵巢癌
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):18-23. doi: 10.1054/bjoc.2000.1758.
10
Research directions in epithelial ovarian cancer.
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S168-73. doi: 10.1006/gyno.1994.1358.

引用本文的文献

1
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.上皮性卵巢癌患者完成初始治疗后的随访策略评估。
Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006119. doi: 10.1002/14651858.CD006119.pub4.
2
Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors.影响卵巢肿瘤术中冰冻切片与最终石蜡病理结果不一致的因素
Front Oncol. 2021 Jul 1;11:694441. doi: 10.3389/fonc.2021.694441. eCollection 2021.
3
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.
妇科癌症患者源性肿瘤细胞的药物基因组学分析。
Genome Biol. 2019 Nov 26;20(1):253. doi: 10.1186/s13059-019-1848-3.
4
Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.全血细胞炎症参数能否为上皮性卵巢癌的预后提供依据？——生存分析。
J Ovarian Res. 2019 Feb 11;12(1):16. doi: 10.1186/s13048-019-0491-7.
5
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.应用卵巢癌风险算法和频繁 CA125 检测对家族性卵巢癌风险升高的女性进行卵巢癌早期检测：两项筛查试验的联合结果。
Clin Cancer Res. 2017 Jul 15;23(14):3628-3637. doi: 10.1158/1078-0432.CCR-15-2750. Epub 2017 Jan 31.
6
A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.铂类辅助治疗对伴有浸润性种植的交界性卵巢肿瘤预后影响的荟萃分析。
Oncologist. 2015 Feb;20(2):151-8. doi: 10.1634/theoncologist.2014-0144. Epub 2015 Jan 19.
7
CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery.CA-125 指示的无症状复发为接受二次细胞减灭术的卵巢癌患者带来生存获益。
J Ovarian Res. 2013 Feb 13;6(1):14. doi: 10.1186/1757-2215-6-14.
8
Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.原发性治疗完成后上皮性卵巢癌患者随访策略的评估
Cochrane Database Syst Rev. 2011 Jun 15(6):CD006119. doi: 10.1002/14651858.CD006119.pub2.
9
[Clinical utility of serous tumoural markers].[浆液性肿瘤标志物的临床应用]
Aten Primaria. 2003;32(4):227-39. doi: 10.1016/s0212-6567(03)79257-9.
10
Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer.
Curr Treat Options Oncol. 2003 Apr;4(2):105-10. doi: 10.1007/s11864-003-0011-1.